Prevalence, incidence and survival of smoldering multiple myeloma in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence, incidence and survival of smoldering multiple myeloma in the United States

Published:2016-10 Issue:10 Volume:6 Page:e486-e486
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Ravindran A,Bartley A C,Holton S J,Gonsalves W I,Kapoor P,Siddiqui M A,Hashmi S K,Marshall A L,Ashrani A A,Dispenzieri A,Kyle R A,Rajkumar S V,Go R S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj2016100.pdf

Reference9 articles.

1. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538–e548.

2. Dispenzieri A, Stewart AK, Chanan-Khan A, Rajkumar SV, Kyle RA, Fonseca R et al. Smoldering multiple myeloma requiring treatment: time for a new definition? Blood 2013; 122: 4172–4181.

3. Kristinsson SY, Holmberg E, Blimark C . Treatment for high-risk smoldering myeloma. New Engl J Med 2013; 369: 1762–1763.

4. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

5. Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 2010; 116: 5501–5506.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities;Blood Cancer Journal;2024-05-28

3. Плазмоклеточные опухоли в гематологических классификациях 2022 г.: WHO-HAEM5 (ВОЗ, 5-й пересмотр) и ICC (Международная консенсусная классификация). Взгляд клинициста;Clinical Oncohematology;2024-04-01

4. Factors Determining Utilization of Stem Cell Transplant for Initial Therapy of Multiple Myeloma by Patient Race: Exploring Intra-racial Healthcare Disparities.;2024-03-12

5. Mode of progression in smoldering multiple myeloma: a study of 406 patients;Blood Cancer Journal;2024-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3